Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche licenses levovirin from ICN

July 3, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Exclusivity period for human gene therapeutic consortium expires

July 3, 2001

Metabolex/Pfizer diabetes partnership gains new focus

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

Barr and Duramed agree to merge

July 3, 2001

ImClone Systems begins fast track approval process for colorectal cancer agent

July 3, 2001

Myocardin, a novel cardiac regulatory gene with potential for heart muscle regeneration

July 3, 2001

NexMed launches Befar in China

July 3, 2001

Liver-targeted complexes of cisplatin and bile acids designed by Spanish group

July 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...